Cogent Biosciences, Inc. (COGT) Total Return Calculator with Dividends Reinvested

Cogent Biosciences, Inc.

Popular:

The total return for Cogent Biosciences, Inc. (COGT) stock is +415.62% over the past 12 months. So far it's up 6.42% this year. The 5-year total return is +394.91%, meaning $10,000 invested in COGT stock 5 years ago would be worth $49,491 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in COGT 1 year ago, it would be worth $51,562 today — you'd have gained $41,562.

With Dividends Reinvested$51,562+415.62%

Price Only (No DRIP)$51,562+415.62%

Period2025-03-04 → 2026-03-03

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in COGT

1Y$51,562+$41,562 (+415.6%)415.6% CAGR

3Y$28,928+$18,928 (+189.3%)42.5% CAGR

5Y$49,491+$39,491 (+394.9%)37.7% CAGR

10Y$8,319-$1,681 (-16.8%)-1.8% CAGR

15Y$8,319-$1,681 (-16.8%)-1.2% CAGR

20Y$8,319-$1,681 (-16.8%)-0.9% CAGR

30Y$8,319-$1,681 (-16.8%)-0.6% CAGR

Cogent Biosciences, Inc. did not pay dividends during this period. Total return = price return.

Loading COGT total return...

As of 2026-03-04

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+6.42%	—	+6.42%	—	$10,642
1Y	+415.62%	415.62%	+415.62%	—	$51,562
3Y	+189.28%	42.49%	+189.28%	—	$28,928
5Y	+394.91%	37.69%	+394.91%	—	$49,491
10Y	-16.81%	-1.82%	-16.81%	—	$8,319
15Y	-16.81%	-1.22%	-16.81%	—	$8,319
20Y	-16.81%	-0.92%	-16.81%	—	$8,319
30Y	-16.81%	-0.61%	-16.81%	—	$8,319

Risk & Highlights

Best Year+355.38%2025

Worst Year-83.89%2019

Max Drawdown-47.59%2025-03-05 → 2025-04-10 · Recovered 2025-07-07

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+11.83%	+11.83%	—	+0.41%	+11.4pp
2025	+355.38%	+355.38%	—	+16.64%	+338.7pp
2024	+25.00%	+25.00%	—	+24.00%	+1.0pp
2023	-46.88%	-46.88%	—	+24.81%	-71.7pp
2022	+32.87%	+32.87%	—	-19.95%	+52.8pp

COGT outperformed the S&P 500 by 397.68pp over the past year (+415.62% vs +17.94%).

Loading summary...

COGT Peers' Total Return

Biotechnology · Top 11 by market cap

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
COGTCogent Biosciences, Inc.	$6.0B	+0.3%	+6.4%	+415.6%	—	+189.3%	+394.9%	-16.8%
AGIOAgios Pharmaceuticals, Inc.	$2.11T	+2.5%	+4.4%	-15.0%	—	+17.4%	-40.0%	-36.0%
VRTXVertex Pharmaceuticals Incorporated	$120.4B	+0.7%	+4.8%	-2.5%	—	+62.5%	+128.0%	+436.2%
REGNRegeneron Pharmaceuticals, Inc.	$107.4B	+0.7%	+0.7%	+16.1%	+0.5pp	+0.6%	+74.7%	+94.4%
ARGXargenx SE	$46.4B	-11.9%	-10.8%	+20.7%	—	+119.3%	+157.4%	+3159.3%
ALNYAlnylam Pharmaceuticals, Inc.	$42.2B	-9.3%	-20.3%	+31.4%	—	+59.8%	+132.3%	+439.2%
BNTXBioNTech SE	$25.4B	-7.1%	+4.5%	-7.8%	—	-23.2%	+8.4%	+624.5%
UTHRUnited Therapeutics Corporation	$22.0B	+4.5%	+1.6%	+63.5%	—	+103.4%	+214.6%	+295.2%
RVMDRevolution Medicines, Inc.	$19.9B	+4.9%	+28.1%	+166.7%	—	+306.0%	+138.5%	+250.4%
INCYIncyte Corporation	$19.6B	-3.7%	-2.6%	+41.7%	—	+30.2%	+27.4%	+37.2%
MRNAModerna, Inc.	$19.4B	+15.7%	+60.4%	+63.0%	—	-65.6%	-62.6%	+166.1%

Compare:COGT vs AGIO COGT vs VRTX COGT vs REGN COGT vs AGIO vs VRTX

About COGT Dividend Returns

Cogent Biosciences, Inc. (COGT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of COGT over the past year?

Cogent Biosciences, Inc. (COGT) delivered a return of 415.62% over the past year. Since COGT does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in COGT be worth today?

A $10,000 investment in Cogent Biosciences, Inc. one year ago would be worth $51,562 today, representing a gain of $41,562.

Q3Does COGT pay dividends?

Cogent Biosciences, Inc. (COGT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For COGT, the total return equals the price-only return.

Q4Did COGT beat the S&P 500?

Yes, Cogent Biosciences, Inc. (COGT) outperformed the S&P 500 by 397.68 percentage points over the past year. COGT delivered a total return of 415.62%, compared to the S&P 500's 17.94%. This 397.68pp alpha means investors in COGT earned more than a passive S&P 500 index fund.

Q5What is COGT's worst drawdown?

Cogent Biosciences, Inc. (COGT) experienced a maximum drawdown of -47.59% over the past year, declining from its peak on 2025-03-05 to its trough on 2025-04-10. The stock recovered to its prior peak by 2025-07-07. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is COGT's long-term total return over 10, 20, or 30 years?

Cogent Biosciences, Inc. (COGT) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -16.8% (-1.8% CAGR) — $10,000 would have grown to $8,319. Over 20 years: -16.8% total return (-0.9% CAGR) — $10,000 → $8,319. Over 30 years: -16.8% total return (-0.6% CAGR) — $10,000 → $8,319. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was COGT's best and worst year?

Cogent Biosciences, Inc.'s best calendar year was 2025 with a total return of 355.4%. Its worst year was 2019 with a total return of -83.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 439.3 percentage points.